Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase NA 1Phase 1 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Lymphoid 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Melanoma 3Squamous Cell Carcinoma of Head and Neck 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Extranodal NK-T-Cell 2Lung Neoplasms 2Immunoblastic Lymphadenopathy 2Head and Neck Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Breast Neoplasms, Male 2Breast Neoplasms 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Sezary Syndrome 1Sarcoma, Kaposi 1Sarcoma 1Rhabdoid Tumor 1Recurrence 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1

Interventions

pembrolizumab 36Nivolumab 32Bevacizumab 13Sunitinib 10Ipilimumab 10aldesleukin 7Interleukin-2 7Axitinib 7lenvatinib 6cabozantinib 6Paclitaxel 6Everolimus 6Docetaxel 6Cyclosporine 6Cyclophosphamide 6fludarabine phosphate 5Sorafenib 5Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5fludarabine 4cemiplimab 4belzutifan 4Whole-Body Irradiation 4Radiosurgery 4Interferon-alpha 4Cetuximab 4durvalumab 3bempegaldesleukin 3avelumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoma, Renal Cell × Immunohistochemistry × Clear all
NCT00788125 2023-07-14

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

City of Hope Medical Center

Phase 1/2 Terminated
7 enrolled 9 charts
CNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Testicular Germ Cell Tumor, Astrocytoma, Burkitt Lymphoma, Carcinoma, Renal Cell, Immunoblastic Lymphadenopathy, Kidney Neoplasms, Liver Neoplasms, Lymphoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Recurrence, Sarcoma, Osteosarcoma, Spinal Cord Neoplasms, Teratoma, Testicular Neoplasms, Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Nephroma, Mesoblastic, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT01582009 2022-08-15

Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

Roswell Park Cancer Institute

Phase 1/2 Terminated
26 enrolled 11 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡